首页> 美国卫生研究院文献>BMC Surgery >Thymic rebound hyperplasia post-chemotherapy mistaken as disease progression in a patient with lymphoma involving mediastinum: a case report and reflection
【2h】

Thymic rebound hyperplasia post-chemotherapy mistaken as disease progression in a patient with lymphoma involving mediastinum: a case report and reflection

机译:胸腺反弹增生后化疗后误认为患有淋巴瘤的患者患者患者:案例报告和反思

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Representative PET/CT or CT images of the superior mediastinal mass in the patient’s chest during treatment. Representative PET/CT images of the anterior mediastinal lesions before treatment, showing multiple lymphadenopathies in the left anterior superior mediastinum and adjacent to the aortic arch, with the maximum SUV of 22 (a); After 8 courses of treatment, anterior mediastinal mass could be still seen (b); 3 months after ASCT, the anterior mediastinal mass disappeared (c); 6 months after ASCT anterior mediastinal mass appeared repeatedly (d); 12 months after ASCT, the anterior mediastinal mass observed similar to that 6 months after ASCT (e)
机译:在治疗期间患者胸腔中优质纵隔物质的代表性PET / CT或CT图像。前纵隔病变的代表性PET / CT图像治疗前,显示左前方纵隔的多个淋巴结病,邻近主动脉弓,最大SUV为22(a);经过8种治疗疗程,静态纵隔物质仍然可以看到(B); ASCT 3个月后,前纵隔物质消失(C); ASCT前纵隔物质重复出现6个月后(D); ASCT后12个月,前纵隔肿块观察到与ASCT(E)之后的6个月相似

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号